Search results
bluebird bio reports first commercial gene therapy use By Investing.com
Investing.com· 1 week agoThis development marks a major step in making the treatment accessible to patients with a history of...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio,...
Benzinga· 1 day agoNEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against bluebird bio, Inc. ("bluebird ...
Regeneron's cell medicines chief is crafting a new cell therapy 'secret sauce'
FierceBiotech· 5 days agoPhil Gregory’s new gig looks a whole lot like his old gig. It’s just that, under the umbrella of...